Genetic Signatures Limited (ASX:GSS)
Australia · Delayed Price · Currency is AUD 0.0870
+0.0060 (7.41%)
Sep 8, 2026, 1:35 PM AEST
Genetic Signatures Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 14.84 | 15.9 | 9.77 | 16.94 | 35.42 |
Other Revenue | 4.49 | 3.85 | 4 | 4.57 | 0.08 |
| 19.33 | 19.75 | 13.77 | 21.51 | 35.5 | |
Revenue Growth | -2.14% | 43.47% | -36.00% | -39.39% | 25.06% |
Cost of Revenue | 10.72 | 9.25 | 7.91 | 11.83 | 13.6 |
Gross Profit | 8.61 | 10.51 | 5.86 | 9.68 | 21.9 |
Selling, General & Admin | 17.38 | 20.4 | 19.11 | 19.44 | 14.67 |
Other Operating Expenses | 2.03 | 2.34 | 3.09 | 3.31 | 2.58 |
Operating Expenses | 21.47 | 25.13 | 24.19 | 24.28 | 18.87 |
Operating Income | -12.86 | -14.63 | -18.33 | -14.59 | 3.03 |
Interest Expense | -0.05 | -0.09 | -0.04 | -0 | -0.02 |
Interest & Investment Income | 0.99 | 1.61 | 0.5 | 0.54 | 0.13 |
Currency Exchange Gain (Loss) | - | - | - | - | -0.09 |
Other Non Operating Income (Expenses) | -0 | - | - | - | 0.01 |
EBT Excluding Unusual Items | -11.93 | -13.11 | -17.86 | -14.05 | 3.06 |
Asset Writedown | -2.08 | -7 | - | - | - |
Pretax Income | -14.01 | -20.1 | -17.86 | -14.05 | 3.06 |
Net Income | -14.01 | -20.1 | -17.86 | -14.05 | 3.06 |
Net Income to Common | -14.01 | -20.1 | -17.86 | -14.05 | 3.06 |
Net Income Growth | - | - | - | - | 74.43% |
Shares Outstanding (Basic) | 227 | 227 | 165 | 143 | 143 |
Shares Outstanding (Diluted) | 227 | 227 | 165 | 143 | 145 |
Shares Change | 0.19% | 37.18% | 15.25% | -1.40% | -0.16% |
EPS (Basic) | -0.06 | -0.09 | -0.11 | -0.10 | 0.02 |
EPS (Diluted) | -0.06 | -0.09 | -0.11 | -0.10 | 0.02 |
EPS Growth | - | - | - | - | 74.39% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -8.82 | -12.94 | -12.1 | -14.38 | 8.09 |
Free Cash Flow Per Share | -0.04 | -0.06 | -0.07 | -0.10 | 0.06 |
Gross Margin | 44.53% | 53.19% | 42.53% | 45.01% | 61.69% |
Operating Margin | -66.55% | -74.06% | -133.14% | -67.83% | 8.54% |
Profit Margin | -72.45% | -101.78% | -129.74% | -65.32% | 8.63% |
Free Cash Flow Margin | -45.62% | -65.52% | -87.88% | -66.86% | 22.80% |
EBITDA | -11.27 | -12.67 | -16.53 | -13.07 | 4.3 |
EBITDA Margin | -58.27% | -64.14% | -120.05% | -60.74% | 12.12% |
D&A For EBITDA | 1.6 | 1.96 | 1.8 | 1.53 | 1.27 |
EBIT | -12.86 | -14.63 | -18.33 | -14.59 | 3.03 |
EBIT Margin | -66.55% | -74.05% | -133.14% | -67.83% | 8.54% |
Advertising Expenses | 0.18 | 0.23 | - | - | - |